Your browser doesn't support javascript.
loading
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection.
Moreno-García, E; Rico, E; Albiach, L; Agüero, D; Ambrosioni, J; Bodro, M; Cardozo, C; Chumbita, M; De la Mora, M; García-Pouton, N; Garcia-Vidal, C; González-Cordón, A; Hernández-Meneses, M; Inciarte, A; Laguno, M; Leal, L; Linares, L; Macay, I; Meira, F; Mensa, J; Moreno, A; Morata, L; Puerta-Alcalde, P; Rojas, J; Solá, M; Torres, B; Torres, M; Tomé, A; Tuset, M; Castro, P; Fernández, S; Nicolás, J M; Almuedo-Riera, A; Muñoz, J; Fernandez-Pittol, M; Marcos, M A; Soy, D; Martínez, J A; García, F; Soriano, A.
Affiliation
  • Soriano A; Alex Soriano, Department of Infectious Diseases, Hospital Clínic of Barcelona. Carrer de Villarroel 170, 08036, Barcelona, Spain. asoriano@clinic.cat.
Rev Esp Quimioter ; 34(3): 238-244, 2021 Jun.
Article in En | MEDLINE | ID: mdl-33829722
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / COVID-19 / Hospitalization / Intensive Care Units Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / COVID-19 / Hospitalization / Intensive Care Units Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Rev Esp Quimioter Journal subject: TERAPIA POR MEDICAMENTOS Year: 2021 Type: Article